Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Six African American women experienced hair loss after switching to a new HIV medication.

Teak leaf extract may effectively and safely promote hair growth in males with androgenic alopecia.

The treatment is effective for mild alopecia areata but often causes mild side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Combination therapy improves hair growth in advanced hair loss.

The document's conclusion cannot be summarized because the content is not available.

The document's conclusion cannot be summarized because the content is not accessible.

Integrative hair therapy improved hair loss and regrowth.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Finasteride can help with hair loss and prostate issues but may negatively affect mood and the nervous system.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

The drug combination was safe and showed promise in treating advanced tumors.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.